Order results by:
| Issue | Title | |
| Vol 15, No 4 (2023) | Clinical experience with the use of citicoline in mild cognitive impairment of vascular origin | Abstract similar documents |
| L. A. Shchepankevich, I. A. Gribacheva, T. F. Popova, E. V. Taneeva, K. V. Roerich, E. V. Petrova, M. S. Shchepankevich | ||
| "... with citicoline (Noocil®) on cognitive function and quality of life (QoL)in patients with mild cognitive ..." | ||
| Vol 14, No 6 (2022) | Mild cognitive impairment treatment issues | Abstract similar documents |
| L. A. Shсhepankevich, I. A. Gribacheva, T. F. Popova, E. V. Taneeva, K. V. Roerich, E. V. Petrova, M. S. Shchepankevich | ||
| "... with citicoline is actualized, increasing adherence to therapy by prescribing a convenient form of the drug Noocil ..." | ||
| Vol 12, No 2 (2020) | The role of citicoline in the treatment of dyscirculatory encephalopathy and vascular cognitive impairment | Abstract similar documents |
| V. A. Golovacheva | ||
| "... Vascular cognitive impairment (VCI) is the main manifestation of dyscirculatory encephalopathy (DEP ..." | ||
| Vol 16, No 5 (2024) | Asthenia and vascular cognitive impairment in young patients after stroke | Abstract similar documents |
| L. A. Shchepankevich, K. V. Rerikh, M. S. Ponomareva, A. V. Zatynko, E. V. Taneeva | ||
| "... and the efficacy and safety of the domestic drug Noocil (citicoline) in the treatment of PSCI and PSA in stroke ..." | ||
| Vol 17, No 3 (2025) | Opportunities for differential diagnosis of vascular cognitive impairment and Alzheimer's disease at the predementia stage | Abstract similar documents |
| D. A. Grishina, A. B. Lokshina, E. A. Metelkina | ||
| "... of choline alfoscerate and citicoline in CI treatment. he discussion includes ways to improve patient ..." | ||
| Vol 13, No 1 (2021) | Cognitive impairment in COVID-19 survivors | Abstract similar documents |
| T. M. Ostroumova, P. A. Chernousov, I. V. Kuznetsov | ||
| "... and the possibility of their correction with citicoline (Noocil®). ..." | ||
| Vol 6, No 3 (2014) | Effect of citicoline on blood pressure variability | Abstract similar documents |
| O. D. Ostroumova, N. Yu. Taranenko | ||
| "... The authors give the results of their investigation dealing with citicoline therapy in patients ..." | ||
| Vol 4, No 4 (2012) | Citicoline for ischemic stroke: ICTUS trial | Abstract similar documents |
| Vladimir Anatolyevich Parfenov | ||
| "... The paper gives data available in the literature on the use of citicoline in an experimental model ..." | ||
| Vol 2, No 3 (2010) | Clinical experience with ceraxon used in ischemic stroke | Abstract similar documents |
| V. A. Parfenov, T. G. Fateyeva, O. V. Kosivtsova | ||
| "... Citicoline (Ceraxon) is a neuroprotective agent used in acute ischemic stroke (IS) and chronic ..." | ||
| Vol 3, No 3 (2011) | Poststroke cognitive impairments and their therapy with ceraxon | Abstract similar documents |
| N. V. Shakhparonova, A. S. Kadykov, E. M. Kashina | ||
| "... Objective: to evaluate the effect of citicoline (ceraxon) on recovery of cognitive functions ..." | ||
| Vol 12, No 4 (2020) | Experience with citicoline in patients with post-stroke cognitive impairment | Abstract similar documents |
| A. N. Bogolepova, S. G. Burd, A. V. Lebedeva, E. A. Kovalenko | ||
| "... Objective: to investigate the efficacy and safety of citicoline (Ceresil® Canon) in patients ..." | ||
| Vol 12, No 4 (2020) | Chemotranscriptome analysis indicates the neurotrophic and neuromodulator effects of a citicoline molecule | Abstract similar documents |
| I. Yu. Torshin, O. A. Gromova, L. V. Stakhovskaya, V. A. Semenov, I. A. Shchukin | ||
| "... Objective: to investigate the effect of citicoline (CTC) on gene transcription. Material ..." | ||
| Vol 8, No 2 (2016) | Neurometabolic therapy in the recovery period of ischemic stroke: impact on quality of life and cognitive functions | Abstract similar documents |
| V. V. Zakharov, N. V. Vakhnina, D. O. Gromova | ||
| "... citicoline in the recovery period of IS are given. The use of citicoline is shown to cause a significant ..." | ||
| Vol 7, No 3 (2015) | The heterogeneity of vascular cognitive impairments and the issues of therapy | Abstract similar documents |
| Elena Anatolyevna Katunina | ||
| "... and 48% after 25 years. The paper reviews the most important trials of citicoline used in CIs. The drug ..." | ||
| Vol 3, No 1 (2011) | Current treatments for brain contusions | Abstract similar documents |
| A. E. Talypov, S. S. Petrikov, Yu. V. Puras, A. A. Solodov, Yu. V. Titova | ||
| Vol 13, No 1 (2021) | Chronic cerebral ischemia and headache in patients in primary care physician's practice | Abstract similar documents |
| V. N. Shishkova, T. V. Adasheva | ||
| "... ) and Neupilept® (citicoline) in this category of patients. ..." | ||
| Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания | Motor function recovery in patients after ischemic stroke | Abstract similar documents |
| Yu. A. Starchina | ||
| "... in post-stroke movement disorders. The use of citicoline to improve motor function recovery is discussed. ..." | ||
| Vol 1, No 3-4 (2009) | CITICOLIN IN THE TREATMENT OF STROKE AND VASCULAR COGNITIVE DISORDERS | Abstract similar documents |
| V. A. Parfenov | ||
| "... Citicolin (ceraxon) is used as a neuroprotector in the treatment of acute stroke and vascular ..." | ||
| Vol 8, No 3 (2016) | Chemoreactome analysis of ethylmethylhydroxypyridine succinate | Abstract similar documents |
| O. A. Gromova, I. Yu. Torshin, L. E. Fedotova, A. N. Gromov | ||
| "... acid and citicoline were used as the molecules of comparison (control molecules). Material ..." | ||
| Vol 7, No 4 (2015) | Some aspects of treatment for cognitive impairments. Cyticolin: pharmacological characteristics, possible benefits, aspects of use | Abstract similar documents |
| N. V. Trofimova, I. S. Preobrazhenskaya | ||
| "... Обзор посвящен фармакокинетическим и фармакодинамическим свойствам цитиколина и его применению при ..." | ||
| Vol 7, No 1 (2015) | Current therapy for chronic cerebrovascular attack | Abstract similar documents |
| A. A. Shmonin, V. S. Krasnov, I. A. Shmonina, E. V. Melnikova | ||
| "... be given in a risk situation and to reduce damage. Citicoline is one of the most test drugs in a group ..." | ||
| Vol 14, No 6 (2022) | Criteria for diagnosis and classification of vascular cognitive impairment | Abstract similar documents |
| A. Y. Emelin, V. Y. Lobzin | ||
| "... Vascular cognitive impairment (VCI) is a very diverse group of conditions that differ ..." | ||
| Vol 15, No 2 (2023) | Vascular cognitive impairment: issues of diagnosis and treatment | Abstract similar documents |
| A. B. Lokshina, D. A. Grishina, V. V. Zakharov | ||
| "... manifest as vascular cognitive impairment (VCI), are of great medical and social importance. VCIs include ..." | ||
| Vol 9, No 2 (2017) | Morphofunctional bases for the development of vascular cognitive and emotional disorders | Abstract similar documents |
| Yu. V. Zhitkova | ||
| "... years with moderate vascular cognitive impairment (VCI) were examined. A relationship of the clinical ..." | ||
| Vol 6, No 1 (2014) | Vascular cognitive impairment | Abstract similar documents |
| N.V. Vakhnina | ||
| "... , clinical features and approaches to diagnosis and therapy of vascular cognitive impairment (emVCI/em ..." | ||
| Vol 8, No 3 (2016) | Diagnosis and treatment of chronic cerebrovascular disease, use of pentoxifylline | Abstract PDF (Eng) similar documents |
| V. A. Parfenov | ||
| "... , by which is meant vascular cognitive impairment (emVCI/em) in modern foreign literature. There are data ..." | ||
| Vol 12, No 4 (2020) | Possibilities of drug therapy for vascular cognitive impairment: a critical view and possible compromises | Abstract similar documents |
| A. Yu. Emelin, V. Yu. Lobzin | ||
| "... To manage patients with vascular cognitive impairment (emVCI/em) is an extremely difficult task, since ..." | ||
| Vol 11, No 3S (2019): Спецвыпуск: когнитивные нарушения, цереброваскулярные заболевания | Vascular cognitive impairment and chronic cerebral ischemia (dyscirculatory encephalopathy) | Abstract similar documents |
| V. A. Parfenov | ||
| "... The paper reviews the literature on vascular cognitive impairment (emVCI/em), the diagnosis widely used ..." | ||
| Vol 16, No 5 (2024) | Clinical features of vascular cognitive impairment | Abstract similar documents |
| O. O. Martynova, N. V. Vakhnina, V. V. Zakharov | ||
| "... Vascular cognitive impairment (emVCI/em) can occur in cerebrovascular disease of varying degree ..." | ||
| Vol 9, No 4 (2017) | Membrane characteristics and vascular cognitive impairment | Abstract PDF (Eng) similar documents |
| Yu. V. Zhitkova, D. R. Khasanova, V. N. Oslopov | ||
| "... Objective: to study the clinical phenomenology of vascular cognitive impairment (emVCI/em ..." | ||
| Vol 6, No 4 (2014) | Cognitive impairments in cerebrovascular disease | Abstract similar documents |
| A. Yu. Emelin | ||
| "... cognitive impairments (emVCI/em). The etiological factors of emVCI/em may be divided into genetic, sociodemographic ..." | ||
| Vol 7, No 1 (2015) | Cognitive impairments in cerebrovascular disease: What is between health and dementia? | Abstract similar documents |
| A. Yu. Emelin | ||
| "... of vascular cognitive impairments (emVCIs/em). It proposes criteria for the diagnosis of emVCIs/em in the early stages ..." | ||
| Vol 14, No 2 (2022) | Possibilities nootropic drugs in non-demented patients with vascular cognitive disorders | Abstract similar documents |
| M. N. Dadasheva, R. V. Gorenkov, V. A. Kruglov, K. N. Dadasheva, D. I. Lebedeva | ||
| "... impairment (emVCI/em). Patients and methods. The study included 150 patients with emVCI/em that does not meet dementia ..." | ||
| Vol 10, No 4 (2018) | Cognitive and motor training for patients with moderate cognitive impairment and mild dementia | Abstract similar documents |
| A. A. Naumenko, I. S. Preobrazhenskaya | ||
| "... method to basic therapy in patients with Alzheimer's disease (AD) and vascular cognitive impairment (emVCI/em ..." | ||
| Vol 16, No 3 (2024) | Impact of COVID-19 on mild vascular cognitive impairment in patients with atrial fibrillation: results of a three-year observational study | Abstract similar documents |
| O. V. Vorob'eva, N. N. Shindryaeva, V. V. Fateeva | ||
| "... The relationship between vascular cognitive impairment (emVCI/em) and atrial fibrillation (AF ..." | ||
| 1 - 35 of 35 Items | ||
Search tips:
- Search terms are case-insensitive
- Common words are ignored
- By default articles containing any term in the query are returned (i.e., OR is implied)
- Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
- Combine multiple words with AND to find articles containing all terms; e.g., education AND research
- Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
- Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
- Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)
